Decentralized Science (DeSci) project BIO Protocol (BIO) officially landed on the Binance exchange yesterday (3rd), reaching a peak of $1.4 upon opening, with a Fully Diluted Valuation (FDV) exceeding 2.4 billion RMB. However, the reaction from DeSci-related tokens in the field was minimal…
After the ten-day new coin mining activity on Binance Launchpool, the DeSci project BIO Protocol concluded and officially entered the Binance spot trading market at 6:00 PM yesterday (also simultaneously listed on exchanges like OKX).
BIO opened at a high of $1.477
Following the opening of BIO yesterday, the token price quickly surged to a peak of $1.477. However, subsequent selling pressure led to a decline in the token price. At the time of writing, BIO had fallen to $0.7489, with an FDV exceeding 2.4 billion USD.
Public investors gained up to 57 times profit
As the first DeSci project to participate in investment on Binance, coupled with public discussions between Binance founder Zhao Changpeng (CZ) and Ethereum founder Vitalik, BIO has garnered significant attention. In terms of fundraising, BIO raised a total of 30.2 million USD through private placements (targeting institutions) and public offerings (targeting retail investors). According to blockchain data analyst Ai Yi’s statistics, in the three rounds of public fundraising, investors’ costs were:
First round: $0.0256
Second round: $0.04277
Third round: $0.06596
Calculating based on yesterday’s peak price of $1.477, public investors could potentially gain up to approximately 57 times profit, with the lowest being 22 times. In response, Chinese crypto influencer and philanthropist disclosed investing 10 ETH in the public offering, receiving over 800,000 tokens and selling half for a profit of 100 ETH:
BIO received a total of 10 ETH, giving over 800,000 tokens, half of which are locked, and the other half in circulation. Just sold all the circulating half, precisely 100 ETH… Congratulations to the BIO family.
DeSci-related token performance?
Due to the hype surrounding BIO, many investors believed that BIO’s listing on Binance would trigger a surge in the DeSci sector and thus placed bets on related tokens. However, according to CoinGecko data, after BIO was listed on Binance yesterday, there was no immediate surge in DeSci concept tokens, including well-known projects like $VITA and $RSC, which did not experience significant fluctuations post-BIO listing. Additionally, previously highly anticipated DeSci meme tokens $URO and $RIF saw substantial declines yesterday, with both experiencing a drop of 20% and 18% in the past 24 hours.
What is BIO Protocol?
BIO Protocol is a DeSci (Decentralized Science) project aiming to become the Y Combinator of on-chain science. The project aims to enable global communities of scientists, patients, and investors to collectively fund, develop, and own new drugs and therapies through its decentralized autonomous organization network, BioDAO. The protocol’s innovative approach addresses critical gaps in traditional research funding, particularly in areas such as rare diseases, longevity science, and emerging health challenges.
Notably, BIO Protocol has attracted funding from prominent crypto and biotech venture capital firms, including 1kx, Boost VC, Sora Ventures, Zee Prime Capital, and the over 3 billion USD biotech fund Northpond Ventures. Furthermore, Binance announced an investment in BIO Protocol in early November, marking their first foray into the DeSci sector.
BIO Roadmap
BIO Token Generation Event (TGE) on January 3rd
BIO to be launched on Solana and Base chains
BioDAO to release new projects
BIO/BioDAO liquidity pools
New BIO Launchpad coming soon
BIO Tokenomics
56% allocated to ecology and community
25.4% allocated to early contributors
18.6% allocated to early supporters
Related Reports
A New Chapter in DeSci! Quantum Biology DAO Launches $QBIO Token, First Issuance by BIO Protocol
Ecological Conservation: Commonwealth Bank of Australia Develops Blockchain for Biodiversity Maintenance, Issues “BioTokens”
Should DAOs also Register for Review? Hong Kong Legislative Councilor Wu Jiezhuang: Suggests Government Emulate Licensing in the Securities Industry